SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-022055
Filing Date
2023-05-01
Accepted
2023-05-01 16:15:58
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-01

Document Format Files

Seq Description Document Type Size
1 ARS ny20008514x3_ars.pdf ARS 4116106
  Complete submission text file 0001140361-23-022055.txt   5670507
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-34079 | Film No.: 23873876
SIC: 2834 Pharmaceutical Preparations